SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Amylin Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, Par Value $.001
(Title of Class of Securities)
032346108
(CUSIP Number)
Marc Weitzen, Esq.
Icahn Capital LP
767 Fifth Avenue, 47th Floor
New York, New York 10153
(212) 702-4388
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 4, 2009
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box / /.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Partners Master Fund LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
5,592,721
8 SHARED VOTING POWER
0
9 SOLE DISPOSITIVE POWER
5,592,721
10 SHARED DISPOSITIVE POWER
0
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,592,721
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.06%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Partners Master Fund II LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
2,057,967
8 SHARED VOTING POWER
0
9 SOLE DISPOSITIVE POWER
2,057,967
10 SHARED DISPOSITIVE POWER
0
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,057,967
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.50%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Partners Master Fund III LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
787,207
8 SHARED VOTING POWER
0
9 SOLE DISPOSITIVE POWER
787,207
10 SHARED DISPOSITIVE POWER
0
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
787,207
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.57%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Offshore LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
8,437,895
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
8,437,895
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,437,895
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.13%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Partners LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
4,533,433
8 SHARED VOTING POWER
0
9 SOLE DISPOSITIVE POWER
4,533,433
10 SHARED DISPOSITIVE POWER
0
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,533,433
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.29%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Onshore LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
4,533,433
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
4,533,433
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,533,433
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.29%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Capital LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
12,971,328
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
12,971,328
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,971,328
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.43%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
IPH GP LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
12,971,328
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
12,971,328
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,971,328
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.43%
14 TYPE OF REPORTING PERSON
OO
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Enterprises Holdings L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
12,971,328
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
12,971,328
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,971,328
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.43%
14 TYPE OF REPORTING PERSON
PN
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Icahn Enterprises G.P. Inc.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
12,971,328
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
12,971,328
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,971,328
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.43%
14 TYPE OF REPORTING PERSON
CO
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Beckton Corp.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
12,971,328
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
12,971,328
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,971,328
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.43%
14 TYPE OF REPORTING PERSON
CO
|
SCHEDULE 13D
AMENDMENT NO. 4
CUSIP No. 032346108
1 NAME OF REPORTING PERSON
Carl C. Icahn
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
12,971,328
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
12,971,328
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,971,328
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.43%
14 TYPE OF REPORTING PERSON
IN
|
SCHEDULE 13D
AMENDMENT NO. 4
Item 1. Security and Issuer
The Schedule 13D filed with the Securities and Exchange Commission ("SEC")
by the Reporting Persons on May 22, 2008 (as amended, the "Initial 13D"), as
amended by amendment No. 1, amendment no. 2 and amendment no. 3 thereto, with
respect to the shares of Common Stock, par value $.001 (the "Shares"), issued by
Amylin Pharmaceuticals, Inc., (the "Issuer"), is hereby amended to furnish the
additional information set forth herein. All capitalized terms contained herein
but not otherwise defined shall have the meanings ascribed to such terms in the
Initial 13D. The address of the principal executive offices of the Issuer is
9360 Towne Centre Drive, San Diego, California 92121.
Item 3. Source and Amount of Funds or Other Consideration
The aggregate purchase price of the 12,971,328 Shares purchased by the
Reporting Persons collectively was $316,400,196 (including commissions). The
source of funding for the purchase of these Shares was the general working
capital of the respective purchasers. The Shares are held by the Reporting
Persons in margin accounts together with other securities. Such margin accounts
may from time to time have debit balances. Part of the purchase price of the
Shares purchased by the Reporting Persons was obtained through margin borrowing.
The Shares purchased by the Reporting Persons are maintained in margin accounts
that include positions in securities in addition to Shares. As of the close of
business on February 3, 2009, the indebtedness of (i) Icahn Partners' margin
account was approximately $25,515,330, (ii) Icahn Master's margin account was
approximately $103,506,072, (iii) Icahn Master II's margin account was
approximately $29,822,299, and (iv) Icahn Master III's margin account was
approximately $6,335,111.
Item 5. Interest in Securities of the Issuer
Item 5(a) of the Initial 13D is hereby amended and restated to read in its
entirety as follows:
(a) As of February 4, 2009, the Reporting Persons may be deemed to
beneficially own, in the aggregate, 12,971,328 Shares, representing
approximately 9.43% of the Issuer's outstanding Shares (based upon the
137,617,353 Shares stated to be outstanding as of October 28, 2008 by the
Issuer in the Issuer's Form 10-Q, filed with the Securities and Exchange
Commission on November 4, 2008).
Item 5(b) of the Initial 13D is hereby amended and restated to read in its
entirety as follows:
(b) Icahn Master has sole voting power and sole dispositive power with
regard to 5,592,721 Shares. Each of Icahn Offshore, Icahn Capital, IPH,
Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn has
shared voting power and shared dispositive power with regard to such
Shares. Icahn Master II has sole voting power and sole dispositive power
with regard to 2,057,967 Shares. Each of Icahn Offshore, Icahn Capital,
IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr.
Icahn has shared voting power and shared dispositive power with regard to
such Shares. Icahn Master III has sole voting power and sole dispositive
power with regard to 787,207 Shares. Each of Icahn Offshore, Icahn Capital,
IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr.
Icahn has shared voting power and shared dispositive power with regard to
such Shares. Icahn Partners has sole voting power and sole dispositive
power with regard to 4,533,433 Shares. Each of Icahn Onshore, Icahn
Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and
Mr. Icahn has shared voting power and shared dispositive power with regard
to such Shares.
Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises
Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn, by virtue of their
relationships to each of Icahn Master, Icahn Master II and Icahn Master III
(as disclosed in Item 2), may be deemed to indirectly beneficially own (as
that term is defined in Rule 13d-3 under the Act) the Shares which each of
Icahn Master, Icahn Master II and Icahn Master III directly beneficially
owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises
Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial
ownership of such Shares for all other purposes. Each of Icahn Onshore,
Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP,
Beckton and Mr. Icahn, by virtue of their relationships to Icahn Partners
(as disclosed in Item 2), may be deemed to indirectly beneficially own (as
that term is defined in Rule 13d-3 under the Act) the Shares which Icahn
Partners directly beneficially owns. Each of Icahn Onshore, Icahn Capital,
IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr.
Icahn disclaims beneficial ownership of such Shares for all other purposes.
Item 5(c) of the Initial 13D is hereby amended by the addition of the
following:
(c)
The following table sets forth all transactions with respect to Shares
effected during the past sixty (60) days by any of the Reporting Persons.
Except as otherwise noted below, all such transactions were purchases of
Shares effected in the open market, and the table includes commissions paid
in per share prices.
Name of Date of No. of Shares Purchase Price Per
Reporting Transaction Purchased Share (U.S.$)
Person
--------------------------------------------------------------------------------
Icahn Partners 1/30/2009 273,846 11.3948
--------------------------------------------------------------------------------
Icahn Partners 2/2/2009 36,418 11.4675
--------------------------------------------------------------------------------
Icahn Master 1/30/2009 339,204 11.3948
--------------------------------------------------------------------------------
Icahn Master 2/2/2009 22,447 11.4675
--------------------------------------------------------------------------------
Icahn Master II 1/30/2009 125,320 11.3948
--------------------------------------------------------------------------------
Icahn Master III 1/30/2009 47,936 11.3948
--------------------------------------------------------------------------------
|
SIGNATURE
After reasonable inquiry and to the best of each of the undersigned
knowledge and belief, each of the undersigned certifies that the information set
forth in this statement is true, complete and correct.
Dated: February 4, 2009
ICAHN PARTNERS MASTER FUND LP
By: /s/ Edward E. Mattner
---------------------
Name: Edward E. Mattner
Title: Authorized Signatory
|
ICAHN PARTNERS MASTER FUND II LP
By: /s/ Edward E. Mattner
---------------------
Name: Edward E. Mattner
Title: Authorized Signatory
|
ICAHN PARTNERS MASTER FUND III LP
By: /s/ Edward E. Mattner
---------------------
Name: Edward E. Mattner
Title: Authorized Signatory
|
ICAHN OFFSHORE LP
By: /s/ Edward E. Mattner
---------------------
Name: Edward E. Mattner
Title: Authorized Signatory
|
ICAHN PARTNERS LP
By: /s/ Edward E. Mattner
---------------------
Name: Edward E. Mattner
Title: Authorized Signatory
|
ICAHN ONSHORE LP
By: /s/ Edward E. Mattner
---------------------
Name: Edward E. Mattner
Title: Authorized Signatory
|
[Signature Page of Schedule 13D Amendment No. 4 - Amylin Pharmaceuticals, Inc.]
ICAHN CAPITAL LP
By: IPH GP LLC, its general partner
By: Icahn Enterprises Holdings L.P., its sole member
By: Icahn Enterprises G.P. Inc., its general partner
By: /s/ Peter K. Shea
-----------------
Name: Peter K. Shea
Title: President
|
IPH GP LLC
By: Icahn Enterprises Holdings L.P., its sole member
By: Icahn Enterprises G.P. Inc., its general partner
By: /s/ Peter K. Shea
-----------------
Name: Peter K. Shea
Title: President
|
ICAHN ENTERPRISES HOLDINGS L.P.
By: Icahn Enterprises G.P. Inc., its general partner
By: /s/ Peter K. Shea
-----------------
Name: Peter Shea
Title: President
|
[Signature Page of Schedule 13D Amendment No. 4 - Amylin Pharmaceuticals, Inc.]
ICAHN ENTERPRISES G.P. INC.
By: /s/ Peter K. Shea
-----------------
Name: Peter K. Shea
Title: President
|
BECKTON CORP.
By: /s/ Edward E. Mattner
---------------------
Name: Edward E. Mattner
Title: Authorized Signatory
|
[Signature Page of Schedule 13D Amendment No. 4 - Amylin Pharmaceuticals, Inc.]
Dated: February 4, 2009
/s/ Carl C. Icahn
-----------------
CARL C. ICAHN
|
[Signature Page of Schedule 13D Amendment No. 4 - Amylin Pharmaceuticals, Inc.]
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From May 2024 to Jun 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2023 to Jun 2024
